x
|
QUARTERLY
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
o
|
TRANSITION
REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
Nevada
|
52-2088326
|
(State
or other jurisdiction of
incorporation
or organization)
|
(I.R.S.
Employer
Identification
No.)
|
Large
accelerated filer
o
|
Accelerated
filer o
|
Non-accelerated
filer o (Do
not check if a smaller reporting company)
|
Smaller
reporting company x
|
Page | |||
PART
I
|
3 | ||
ITEM
1. Financial Statements
|
3 | ||
Condensed
consolidated balance sheets (unaudited)
|
3 | ||
Condensed
consolidated statements of operations (unaudited)
|
4 | ||
Condensed
consolidated statement of changes in stockholders’ deficiency
(unaudited)
|
5 | ||
Condensed
consolidated statements of cash flows (unaudited)
|
14 | ||
Notes
to condensed consolidated financial statements
(unaudited)
|
16 | ||
ITEM
2. Management’s Discussion and Analysis of Financial Condition and
Results of Operations
|
29 | ||
ITEM
3. Quantitative and Qualitative Disclosure About Market
Risk
|
38 | ||
ITEM
4. Controls and Procedures
|
38 | ||
PART
II
|
40 | ||
ITEM
1. Legal Proceedings
|
40 | ||
ITEM
1A. Risk Factors
|
41 | ||
ITEM
2. Unregistered Sales of Equity Securities and Use of
Proceeds
|
41 | ||
ITEM
3. Defaults Upon Senior Securities
|
42 | ||
ITEM
4. Submission of Matters to a Vote of Security
Holders
|
42 | ||
ITEM
5. Other Information
|
43 | ||
ITEM
6. Exhibits
|
43 | ||
SIGNATURES
|
44 | ||
EXHIBIT
INDEX
|
45 | ||
EXHIBIT
31.1
|
|||
EXHIBIT
31.2
|
|||
EXHIBIT
32
|
September
30, 2009
(unaudited)
|
December
31,
2008
|
|||||||
ASSETS
|
||||||||
Current
assets
|
||||||||
Cash
|
$
|
8,378
|
$
|
59,346
|
||||
Other
current assets
|
13,195
|
33,275
|
||||||
Total
current assets
|
21,573
|
92,621
|
||||||
Property and Equipment, net of
accumulated depreciation and amortization of $136,149
and $111,193, respectively
|
107,013
|
131,969
|
||||||
Other
assets
|
11,020
|
11,250
|
||||||
Total
assets
|
$
|
139,606
|
$
|
235,840
|
||||
LIABILITIES
AND STOCKHOLDERS’ DEFICIENCY
|
||||||||
Current
liabilities
|
||||||||
Accounts
payable-related parties
|
$
|
170,750
|
$
|
93,003
|
||||
Accounts
payable-License Agreements
|
852,750
|
716,500
|
||||||
Accounts
payable-other
|
497,269
|
384,467
|
||||||
Accrued
expenses
|
1,126,119
|
803,795
|
||||||
Accrued
professional fees
|
455,999
|
390,535
|
||||||
Loans
payable-related parties and shareholders
|
102,628
|
78,280
|
||||||
Convertible
debentures, net-related parties
|
56,832
|
12,466
|
||||||
Convertible
debentures, net-others
|
898,545
|
290,659
|
||||||
Total
current liabilities
|
$
|
4,160,892
|
2,769,705
|
|||||
Commitments
and contingencies
|
||||||||
Stockholders’
deficiency
|
||||||||
Common
stock, $.001 par value: 200,000,000 shares authorized, 65,959,620 and
62,940,891 shares issued and outstanding at September 30, 2009 and
December 31, 2008, respectively
|
65,960
|
62,941
|
||||||
Common
stock to be issued (97,059 shares at December 31,
2008)
|
-
|
16,500
|
||||||
Additional
paid-in capital
|
41,938,994
|
40,129,758
|
||||||
Deficit
accumulated during the development stage
|
(46,026,240)
|
(42,743,064
|
)
|
|||||
Total
stockholders’ deficiency
|
(4,021,286)
|
(2,533,865
|
)
|
|||||
Total
liabilities and stockholders’ deficiency
|
$
|
139,606
|
$
|
235,840
|
Three
months ended
September
30,
|
Nine
months ended
September
30,
|
For
the Period From February
18, 1998 (Date of Inception) through
|
||||||||||||||||||
2009
|
2008
|
2009
|
2008
|
September
30, 2009
|
||||||||||||||||
Net
sales
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
-
|
$
|
69,000
|
||||||||||
Cost
of goods sold
|
-
|
-
|
-
|
-
|
24,120
|
|||||||||||||||
Gross
profit
|
-
|
-
|
-
|
-
|
44,880
|
|||||||||||||||
Operating
expenses
|
488,281
|
1,148,887
|
1,923,703
|
2,428,889
|
31,850,643
|
|||||||||||||||
Research
and development expenses
|
12,517
|
109,822
|
274,577
|
432,184
|
5,733,170
|
|||||||||||||||
Non-cash
patent settlement costs
|
-
|
-
|
-
|
-
|
1,610,066
|
|||||||||||||||
Loss
before other income (expense)
|
(500,798)
|
(1,258,709)
|
(2,198,280)
|
(2,861,073)
|
(39,148,999
|
)
|
||||||||||||||
Other
income (expense)
|
||||||||||||||||||||
Other
income (expense)
|
-
|
(30)
|
-
|
533
|
(1,140
|
)
|
||||||||||||||
Interest
income
|
-
|
-
|
-
|
2
|
16,342
|
|||||||||||||||
Interest
expense
|
(250,616)
|
|
(220,400
|
)
|
(1,084,896)
|
(708,959)
|
(7,039,202
|
)
|
||||||||||||
Loss
on sale of equipment
|
-
|
-
|
(9,683)
|
(14,426
|
)
|
|||||||||||||||
Settlement
of debt due Morale/Matthews
|
-
|
-
|
-
|
(927,903)
|
(927,903
|
)
|
||||||||||||||
Settlement
of litigation and debt
|
-
|
-
|
-
|
52,070
|
1,089,088
|
|||||||||||||||
Net
loss
|
$
|
(751,414)
|
|
$
|
(1,4,79,139)
|
$
|
(3,283,176)
|
$
|
(4,455,013)
|
$
|
(46,026,240
|
)
|
||||||||
Net
loss per share, basic and diluted
|
$
|
(0.01)
|
|
$
|
(0.03)
|
$
|
(0.05)
|
$
|
(0.10)
|
|||||||||||
Weighted
average shares outstanding, basic and diluted
|
65,653,349
|
47,312,880
|
64,891,529
|
45,374,117
|
Price
per
|
Common
Stock
|
Common
Stock
to
be
|
Additional
Paid-in
|
Deferred
|
Deficit
Accumulated
During
the
Development
|
Total
Stockholders’
|
|||||||||||||||||||||||||
Share
|
Shares
|
Amount
|
Issued
|
Capital
|
Compensation
|
Stage
|
Deficiency
|
||||||||||||||||||||||||
Balance, February 18,
1998 (date of inception)
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
$
|
—
|
||||||||||||||||||
Issuance
of common stock on April 18, 1998
|
.0015 -
.01
|
10,030,000
|
10,030
|
—
|
14,270
|
—
|
—
|
24,300
|
|||||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
(21,307
|
)
|
(21,307
|
)
|
||||||||||||||||||||||
Balance,
December 31, 1998
|
10,030,000
|
$
|
10,030
|
$
|
—
|
14,270
|
$
|
—
|
$
|
(21,307
|
)
|
$
|
2,993
|
||||||||||||||||||
Issuance
of common stock on May 18, 1999
|
1.00 -
6.40
|
198,003
|
198
|
—
|
516,738
|
—
|
—
|
516,936
|
|||||||||||||||||||||||
Issuance
of common stock for ZEFS on September 14, 1999
|
.001
|
5,000,000
|
5,000
|
—
|
—
|
—
|
—
|
5,000
|
|||||||||||||||||||||||
Stock
issued for professional services on May 18, 1999
|
0.88
|
69,122
|
69
|
—
|
49,444
|
—
|
—
|
49,513
|
|||||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
(1,075,264
|
)
|
(1,075,264
|
)
|
||||||||||||||||||||||
Balance,
December 31, 1999
|
15,297,125
|
$
|
15,297
|
$
|
—
|
$
|
580,452
|
$
|
—
|
$
|
(1,096,571
|
)
|
$
|
(500,822
|
)
|
Price
per
|
Common
Stock
|
Common
Stock
to
be
|
Additional
Paid-in
|
Deferred
|
Deficit
Accumulated
During
the
Development
|
Total
Stockholders’
|
||||||||||||||||||
Share
|
Shares
|
Amount
|
Issued
|
Capital
|
Compensation
|
Stage
|
Deficiency
|
|||||||||||||||||
Balance,
December 31, 1999
|
15,297,125
|
$
|
15,297
|
$
|
—
|
$
|
580,452
|
$
|
—
|
$
|
(1,096,571
|
) |
$
|
(500,822
|
)
|
|||||||||
Issuance
of common stock for services
|
$0.38 -
$5.31
|
305,810
|
306
|
—
|
588,704
|
—
|
—
|
589,010
|
||||||||||||||||
Stock
issued for employee compensation on February 8, 2000
|
$1.03-$5.31
|
42,000
|
42
|
—
|
137,378
|
—
|
—
|
137,420
|
||||||||||||||||
Stock
issued for directors fees
|
$3.38-$4.44
|
56,000
|
56
|
—
|
195,584
|
—
|
—
|
195,640
|
||||||||||||||||
Common
stock cancelled
|
(55,000
|
) |
(55
|
) |
(64,245
|
) |
(64,300
|
)
|
||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
(1,270,762
|
)
|
(1,270,762
|
)
|
|||||||||||||||
Balance,
December 31, 2000
|
15,645,935
|
15,646
|
—
|
1,437,873
|
—
|
(2,367,333
|
)
|
(913,814
|
)
|
|||||||||||||||
Issuance
of common stock for services
|
$0.25-$1.65
|
1,339,912
|
1,340
|
—
|
1,031,231
|
—
|
—
|
1,032,571
|
||||||||||||||||
Stock
issued for directors fees
|
$0.60-$0.95
|
1,100,000
|
1,100
|
1,008,900
|
1,010,000
|
|||||||||||||||||||
Intrinsic
value of options issued to employees
|
2,600,000
|
(2,600,000)
|
—
|
|||||||||||||||||||||
Fair
value of options issued to non-employees
|
142,318
|
142,318
|
||||||||||||||||||||||
Amortization
of deferred compensation
|
191,667
|
191,667
|
||||||||||||||||||||||
Net
loss
|
(2,735,013
|
) |
(2,735,013
|
)
|
||||||||||||||||||||
Balance,
December 31, 2001
|
18,085,847
|
$
|
18,086
|
$
|
—
|
$
|
6,220,322
|
$
|
(2,408,333
|
) |
$
|
(5,102,346
|
)
|
$
|
(1,272,271
|
) |
Price
per
|
Common
Stock
|
Common
Stock
to
be
|
Additional
Paid-in
|
Deferred
|
Deficit
Accumulated
During
the
Development
|
Total
Stockholders’
|
|||||||||||||||||||||||||
Share
|
Shares
|
Amount
|
Issued
|
Capital
|
Compensation
|
Stage
|
Deficiency
|
||||||||||||||||||||||||
Balance,
December 31, 2001
|
18,085,847
|
$
|
18,086
|
$
|
—
|
$
|
6,220,322
|
$
|
(2,408,333
|
) |
$
|
(5,102,346
|
) |
$
|
(1,272,271
|
) | |||||||||||||||
Stock
issued for directors fees
|
0.40
|
2,150,000
|
2,150
|
—
|
857,850
|
—
|
—
|
860,000
|
|||||||||||||||||||||||
Common
stock sold (2,305,000
shares)
|
0.15-0.25
|
—
|
—
|
389,875
|
—
|
—
|
—
|
389,875
|
|||||||||||||||||||||||
Fair
value of options issued to non-employees for services
|
—
|
—
|
—
|
54,909
|
(54,909
|
)
|
—
|
—
|
|||||||||||||||||||||||
Amortization
of deferred compensation
|
—
|
—
|
—
|
—
|
891,182
|
—
|
891,182
|
||||||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
(2,749,199
|
)
|
(2,749,199
|
)
|
||||||||||||||||||||||
Balance,
December 31, 2002
|
20,235,847
|
20,236
|
389,875
|
7,133,081
|
(1,572,060)
|
(7,851,545
|
)
|
(1,880,413
|
)
|
||||||||||||||||||||||
Common
stock issued previously paid for
|
0.15-0.25
|
2,305,000
|
2,305
|
(433,750
|
)
|
431,445
|
—
|
—
|
—
|
||||||||||||||||||||||
Sale
of common stock
|
$ |
0.25
|
9,504,000
|
9,504
|
2,366,439
|
—
|
—
|
2,375,943
|
|||||||||||||||||||||||
Issuance
of common stock for services
|
$ |
0.55
|
83,414
|
83
|
—
|
45,794
|
—
|
—
|
45,877
|
||||||||||||||||||||||
Common
stock issued for convertible debt
|
$ |
0.25
|
2,000,000
|
2,000
|
498,000
|
—
|
—
|
500,000
|
|||||||||||||||||||||||
Finders’
fees related to stock issuances
|
—
|
—
|
43,875
|
(312,582
|
)
|
—
|
—
|
(268,707
|
) | ||||||||||||||||||||||
Common
stock
sold
(25,000
shares)
|
0.25
|
—
|
—
|
6,250
|
—
|
—
|
—
|
6,250
|
|||||||||||||||||||||||
Amortization
of deferred comp
|
—
|
—
|
—
|
—
|
863,727
|
—
|
863,727
|
||||||||||||||||||||||||
Net
loss
|
(2,476,063
|
) |
(2,476,063
|
) | |||||||||||||||||||||||||||
Balance,
December 31, 2003
|
34,128,261
|
$
|
34,128
|
$
|
6,250
|
$
|
10,162,177
|
$
|
(708,333
|
) |
$
|
(10,327,608
|
)
|
$
|
(833,386
|
)
|
Price
per
|
Common
Stock
|
Common
Stock
to
be
|
Additional
Paid-in
|
Deferred
|
Deficit
Accumulated
During
the
Development
|
Total
Stockholders’
|
||||||||||||||||||||||||
Share
|
Shares
|
Amount
|
Issued
|
Capital
|
Compensation
|
Stage
|
Deficiency
|
|||||||||||||||||||||||
Balance,
December 31, 2003
|
34,128,261
|
$
|
34,128
|
$
|
6,250
|
$
|
10,162,177
|
$
|
(708,333
|
) |
$
|
(10,327,608
|
)
|
$
|
(833,386
|
) | ||||||||||||||
Common
stock issued previously
paid for
|
$ |
.25
|
25,000
|
25
|
(6,250)
|
6,225
|
—
|
|||||||||||||||||||||||
Sale
of common stock
|
$ |
1.00
|
1,272,500
|
1,273
|
119,000
|
1,271,227
|
—
|
—
|
1,391,500
|
|||||||||||||||||||||
Stock
issued for services
|
$ |
.15-$1.70
|
1,268,560
|
1,
|
1,268
|
1,388,663
|
1,389,931
|
|||||||||||||||||||||||
Stock
issued for directors fees
|
$ |
1.50
|
50,000
|
50
|
—
|
74,950
|
—
|
—
|
75,000
|
|||||||||||||||||||||
Common
stock issued for convertible debt
|
$ |
1.53
|
60,000
|
60
|
91,740
|
—
|
—
|
91,800
|
||||||||||||||||||||||
Common
stock issued upon exercise of warrants and options
|
$ |
.20
-$.40
|
960,500
|
960
|
—
|
193,240
|
—
|
—
|
194,200
|
|||||||||||||||||||||
Common
stock issued for patent settlement
|
$ |
1.24
|
20,000
|
20
|
24,780
|
24,800
|
||||||||||||||||||||||||
Fair
value of warrants issued
|
1,614,138
|
1,614,138
|
||||||||||||||||||||||||||||
Fair
value of options issued to employees
|
—
|
—
|
—
|
248,891
|
(248,891
|
)
|
—
|
—
|
||||||||||||||||||||||
Fair
value of options issued to non-employees
|
—
|
—
|
—
|
55,381
|
(55,381
|
)
|
—
|
—
|
||||||||||||||||||||||
Amortization
of deferred compensation
|
—
|
—
|
—
|
—
|
936,537
|
—
|
936,537
|
|||||||||||||||||||||||
Finders’
fees related to stock issuances
|
(88,384
|
) | ||||||||||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
(6,803,280
|
)
|
(6,803,280
|
)
|
|||||||||||||||||||||
Balance,
December 31, 2004
|
37,784,821
|
$
|
37,784
|
$
|
119,000
|
$
|
15,043,028
|
$
|
(76,068
|
) |
$
|
(17,130,888
|
)
|
$
|
(2,007,144
|
)
|
Price
per
|
Common
Stock
|
Common
Stock
to
be
|
Additional
Paid-in
|
Deferred
|
Deficit
Accumulated
During
the
Development
|
Total
Stockholders’
|
|||||||||||||||||||||
Share
|
Shares
|
Amount
|
Issued
|
Capital
|
Compensation
|
Stage
|
Deficiency
|
||||||||||||||||||||
Balance,
December 31, 2004
|
37,784,821
|
$
|
37,784
|
$
|
119,000
|
$
|
15,043,028
|
$
|
(76,068
|
) |
$
|
(17,130,888
|
)
|
$
|
(2,007,144
|
) | |||||||||||
Common
stock issued previously paid for
|
$1.00
|
119,000
|
119
|
(119,000
|
) |
118,881
|
—
|
—
|
—
|
||||||||||||||||||
Sale
of common stock
|
$1.00
|
1,530,500
|
1,530
|
1,528,970
|
—
|
—
|
1,530,500
|
||||||||||||||||||||
Common
stock issued upon exercise of warrants
|
$.40
- $1.00
|
500
|
1
|
—
|
199
|
—
|
—
|
200
|
|||||||||||||||||||
Common
stock to be issued for settlement of payables
|
612,521
|
612,521
|
|||||||||||||||||||||||||
Fair
value of options issued for settlement costs
|
31,500
|
31,500
|
|||||||||||||||||||||||||
Fair
value of warrants issued
|
18,462
|
18,462
|
|||||||||||||||||||||||||
Fair
value of warrants issued and intrinsic value of beneficial conversion
associated with convertible notes
|
1,453,181
|
1,453,181
|
|||||||||||||||||||||||||
Fair
value of options issued to employees
|
—
|
—
|
—
|
243,750
|
(243,750
|
)
|
—
|
—
|
|||||||||||||||||||
Amortization
of deferred compensation
|
—
|
—
|
—
|
—
|
177,631
|
—
|
177,631
|
||||||||||||||||||||
Finders’
fees related to stock issuances
|
(109,840
|
) |
(109,840
|
) | |||||||||||||||||||||||
Common
stock cancelled
|
(8,047,403
|
) |
(8,047
|
) |
8,047
|
—
|
|||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
(3,115,186
|
)
|
(3,115,186
|
)
|
||||||||||||||||||
Balance,
December 31, 2005
|
31,387,418
|
$
|
31,387
|
$
|
612,521
|
$
|
18,336,178
|
$
|
(142,187
|
) |
$
|
(20,246,074
|
)
|
$
|
(1,408,175
|
)
|
Price
per
|
Common
Stock
|
Common
Stock
to
be
|
Additional
Paid-in
|
Deferred
|
Deficit
Accumulated
During
the
Development
|
Total
Stockholders’
|
|||||||||||||||||||||
Share
|
Shares
|
Amount
|
Issued
|
Capital
|
Compensation
|
Stage
|
Deficiency
|
||||||||||||||||||||
Balance,
December 31, 2005
|
31,387,418
|
$
|
31,387
|
$
|
612,521
|
$
|
18,336,178
|
$
|
(142,187)
|
$
|
(20,246,074
|
)
|
$
|
(1,408,175
|
) | ||||||||||||
Common
stock issued previously paid for
|
846,549
|
847
|
(612,521
|
) |
611,674
|
—
|
—
|
—
|
|||||||||||||||||||
Sale
of common stock
|
$1.00
- $1.89
|
1,360,537
|
1,360
|
60,000
|
2,401,048
|
—
|
—
|
2,462,408
|
|||||||||||||||||||
Common
stock issued upon exercise of warrants
|
$.50
- $1.50
|
2,583,533
|
2,584
|
—
|
1,794,944
|
—
|
—
|
1,797,528
|
|||||||||||||||||||
Common
stock to be issued for convertible debt
|
$.70
|
3,416,186
|
3,417
|
2,356,449
|
2,359,866
|
||||||||||||||||||||||
Common
stock to be issued for out of line of credit
|
$.55
- $1.22
|
487,483
|
|
487
|
379,610
|
380,097
|
|||||||||||||||||||||
Fair
value of options issued to employees
|
—
|
—
|
—
|
2,253,263
|
—
|
2,253,263
|
|||||||||||||||||||||
Fair
value of options issued for settlement costs
|
31,500
|
31,500
|
|||||||||||||||||||||||||
Fair
value of warrants issued for services
|
463,627
|
463,627
|
|||||||||||||||||||||||||
Fair
value of warrants issued and intrinsic value of beneficial conversion
associated with convertible notes
|
1,259.696
|
1,259,696
|
|||||||||||||||||||||||||
Write
off of deferred compensation
|
—
|
—
|
—
|
(142,187
|
) |
142,187
|
—
|
—
|
|||||||||||||||||||
Finders’
fees related to stock issuances
|
(284,579
|
) |
(284,579
|
) | |||||||||||||||||||||||
Fees
paid on equity line of credit
|
(30,402
|
) |
(30,402
|
) | |||||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
(10,181,523
|
)
|
(10,181,523
|
)
|
||||||||||||||||||
Balance,
December 31, 2006
|
40,081,757
|
$
|
40,082
|
$
|
60,000
|
$
|
29,430,821
|
$
|
—
|
$
|
(30,427,597
|
)
|
$
|
(896,694
|
)
|
Price
per
|
Common
Stock
|
Common
Stock
to
be
|
Additional
Paid-in
|
Deficit
Accumulated
During
the
Development
|
Total
Stockholders’
|
||||||||||||||||||||
Share
|
Shares
|
Amount
|
Issued
|
Capital
|
Stage
|
Deficiency
|
|||||||||||||||||||
Balance,
December 31, 2006
|
40,081,757
|
$
|
40,082
|
$
|
60,000
|
$
|
29,430,821
|
$
|
(30,427,597
|
)
|
$
|
(896,694
|
) | ||||||||||||
Common
stock issued previously paid for
|
2,597,524
|
2,598
|
(60,000
|
) |
57,402
|
—
|
—
|
||||||||||||||||||
Common
stock to be issued for convertible debt
|
$.17
- $.53
|
1,910,711
|
1,911
|
524,569
|
526,480
|
||||||||||||||||||||
Common
stock issued for put of line of
credit
|
$.27
- $.73
|
1,880,421
|
1,880
|
990,175
|
992,055
|
||||||||||||||||||||
Common
stock granted for services
|
4,000
|
4,000
|
|||||||||||||||||||||||
Fair
value of options issued to employees
|
—
|
—
|
—
|
67,592
|
—
|
67,592
|
|||||||||||||||||||
Fair
value of warrants issued for services
|
35,340
|
35,340
|
|||||||||||||||||||||||
Fair
value of warrants issued and intrinsic value of beneficial conversion
associated with convertible notes
|
1,253,548
|
1,253,548
|
|||||||||||||||||||||||
Fees
paid on equity line of credit
|
(79,364
|
) |
(79,364
|
) | |||||||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
(6,262,743
|
)
|
(6,262,743
|
)
|
|||||||||||||||||
Balance,
December 31, 2007
|
46,470,413
|
$
|
46,471
|
$
|
4,000
|
$
|
32,280,083
|
$
|
(36,690,340
|
)
|
$
|
(4,359,786
|
)
|
Price
per
|
Common
Stock
|
Common
Stock
to
be
|
Additional
Paid-in
|
Deficit
Accumulated
During
the
Development
|
Total
Stockholders’
|
||||||||||||||||||||
Share
|
Shares
|
Amount
|
Issued
|
Capital
|
Stage
|
Deficiency
|
|||||||||||||||||||
Balance,
December 31, 2007
|
46,470,413
|
$
|
46,471
|
$
|
4,000
|
$
|
32,280,083
|
$
|
(36,690,340
|
)
|
$
|
(4,359,786
|
)
|
||||||||||||
Common
stock issued for convertible debt
|
$.17
- $.53
|
5,575,082
|
5,574
|
16,500
|
1,936,171
|
—
|
1,958,245
|
||||||||||||||||||
Common
stock issued for Morale/ Matthews settlement
|
$.38
|
7,421,896
|
7,422
|
—
|
2,776,289
|
—
|
2,783,711
|
||||||||||||||||||
Common
stock issued for services
|
$.17
- $.49
|
2,398,850
|
2,399
|
—
|
516,230
|
—
|
518,629
|
||||||||||||||||||
Common
stock issued upon exercise of warrants
|
$.50
|
1,064,650
|
1,065
|
—
|
531,260
|
—
|
532,325
|
||||||||||||||||||
Fair
value of options issued as compensations
|
—
|
—
|
—
|
—
|
645,745
|
—
|
645,745
|
||||||||||||||||||
Fair
value of warrants issued and intrinsic value of beneficial conversion
associated with convertible notes
|
—
|
—
|
—
|
—
|
1,323,077
|
—
|
1,323,077
|
||||||||||||||||||
Fair
value of warrants issued to PIPE holders
|
—
|
—
|
—
|
—
|
116,913
|
—
|
116,913
|
||||||||||||||||||
Common
stock issued for services
|
0.17
|
10,000
|
10
|
(4,000
|
)
|
3,990
|
—
|
—
|
|||||||||||||||||
Net
loss
|
—
|
—
|
—
|
—
|
—
|
(6,052,724
|
)
|
(6,052,724
|
|||||||||||||||||
Balance,
December 31, 2008
|
62,940,891
|
$
|
62,941
|
$
|
16,500
|
$
|
40,129,758
|
$
|
(42,743,064
|
)
|
$
|
(2,533,865
|
)
|
Price
per
|
Common
Stock
|
Common
Stock
to
be
|
Additional
Paid-in
|
Deficit
Accumulated
During
the
Development
|
Total
Stockholders’
|
||||||||||||||||||||
Share
|
Shares
|
Amount
|
Issued
|
Capital
|
Stage
|
Deficiency
|
|||||||||||||||||||
Balance,
December 31, 2008
|
62,940,891
|
$
|
62,941
|
$
|
16,500
|
$
|
40,129,758
|
$
|
(42,743,064
|
)
|
$
|
(2,533,865
|
)
|
||||||||||||
Common
stock issued for convertible debt
|
0.15
- 0.50
|
2,165,026
|
2,165
|
(16,500
|
) |
474,464
|
—
|
460,129
|
|||||||||||||||||
Common
stock issued for services
|
0.17
- 0.49
|
340,000
|
340
|
—
|
137,160
|
—
|
137,500
|
||||||||||||||||||
Common
stock issued for settlement of accounts payable
|
0.27
|
430,370
|
431
|
|